Three of the biggest makers of diabetes treatments have been accused of price fixing. A lawsuit filed this week claims that Sanofi, Novo Nordisk and Eli Lilly have been conspiring to drive up prices of insulin at the expense of their patients. Because of the high prices, the suit says some patients have been using expired insulin or starving themselves to control their blood sugar. The drug makers say the allegations have no merit.
Click the above audio player to hear the full story.
As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.
Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.
Donate today — in any amount — to become a Marketplace Investor. Now more than ever, your commitment makes a difference.
Thanks to our
Your support keeps us going strong, even through